Resources
News

Michael K. Fee to Lead Verrill’s Nationally-Recognized Health Care and Life Sciences Practice Amidst Recent Changes

August 31, 2020 Press Releases

(August 31, 2020) – Verrill is pleased to announce Michael K. Fee as the new leader of Verrill’s nationally-recognized Health Care & Life Sciences Group. The Group has a long history of representing a broad range of providers, insurers, and other participants in the health care field. Fee joined the Group during the past year, bringing to it preeminent skills and experience as a white collar defense litigator and health care fraud and abuse advisor.

At the same time, Verrill is announcing the dissolution of a portion of its practice group focused on academic and clinical research matters. “We are naturally sorry to see colleagues in this niche field depart,” Fee commented. “But it will not impact Verrill’s longstanding and vibrant health care practice. We will continue to serve clients of all kinds who operate in the complex and highly regulated health care field.”

Verrill provides a full spectrum of legal services to organizations and individual professionals in health care. Through multidisciplinary collaboration, Verrill assists with critical matters like strategic affiliations and transactions, privacy and security, reimbursement, regulatory compliance, and the defense of health care industry players in government enforcement proceedings and litigation. The health care practice has experienced a great deal of growth over recent years, including the expansion of the health care and life sciences defense practice that Fee also leads.

“I am excited to lead such a strong array of attorneys with decades of experience and stature in the health care field. As our clients look to us now more than ever amidst the current pandemic, we will continue to serve the ever-evolving needs of our clients throughout New England and beyond, providing them with the highest level of client service and value they know and expect,” added Fee.

Verrill’s Health Care and Life Sciences Group and its Health Care Industry Group, composed of 20 Partners and Counsel, supported by energetic and talented associates, remain focused on using their unmatched knowledge and skill to deliver the highest level of client service to the firm’s health care industry clients from three of Verrill’s offices in New England.

Firm Highlights

News

Verrill Welcomes Jeffrey A. Smagula, Experienced Health Care and Life Sciences Attorney, Former Health Plan Compliance Executive

(May 12, 2021) – Verrill is pleased to welcome Jeffrey A. Smagula to the firm’s Boston office as Counsel in its nationally recognized Health Care & Life Sciences Group. Jeff Smagula brings to Verrill...

Matter

Patent Litigation: Medical Device

Defended company medical device manufacturer against claimed infringement of expired patent relating to laser hair removal; obtained stay of matter pending reexamination of patent, which resulted in cancelling of all allegedly infringing claims and...

Publication/Podcast

“If I've told you once, I've told you eight times…” HHS OIG Issues Another Audit Report on Hospitals’ Failure to Report Credits for Explanted Cardiac Devices and Lays the Groundwork Collection of Overpayments

Publication/Podcast

Fraud and Abuse Investigations Handbook for the Health Care Industry, Second Edition.

Health care attorney Paul Shaw co-authored Fraud and Abuse Investigations Handbook for the Health Care Industry, Second Edition with Robert Griffith, published by the American Health Law Association (AHLA). Paul and Robert provide legal...

Publication/Podcast

Massachusetts Health Care Bill Makes Several Significant Changes

While you were celebrating the New Year, Governor Baker signed Chapter 260 of the Acts of 2020, an “Act promoting a resilient health care system that puts patients first,” the result of the Legislature’s...

Publication/Podcast

Hospital Price Transparency Rule: Full Steam Ahead

Neither COVID-19 nor continued legal challenges appear likely to derail the Centers for Medicare & Medicaid Services ( CMS) Hospital Price Transparency Rule from going into effect on January 1, 2021. Hospitals therefore should...

News

65 Verrill Attorneys Recognized by Best Lawyers® 2022, Including Eight Named Lawyers of the Year

(August 31, 2021) – 65 Verrill attorneys were recognized as "Best Lawyers" by Best Lawyers® 2022 , including 8 attorneys named “Lawyer of the Year,” a distinguished recognition for only a single lawyer in...

Publication/Podcast

HHS Confirms Providers’ Right to 340B Discount Pricing for Contract Pharmacies

As a holiday gift to providers, the U.S. Department of Health and Human Services (HHS) General Counsel recently issued a strongly worded Advisory Opinion indicating that federal law requires drug manufacturers to deliver covered...

Publication/Podcast

340B Providers Get Partial Relief from New Dispute Resolution Regulation

1. 340B ADR Process Established At long last, more than ten years after Congress directed it to do so, HHS has finalized an alternative dispute resolution (“ADR”) process for both providers and pharmaceutical manufacturers...

Publication/Podcast

The Regulatory Sprint is Over - What’s at the Finish Line Under the New Stark and AKS Final Rules?

The U.S. Department of Health and Human Services (HHS) completed its “Regulatory Sprint” by finalizing changes to regulations pertaining to two federal fraud and abuse laws. On December 2, 2020, the Centers for Medicare...

Contact Verrill at (855) 307 0700